These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3662060

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of ketanserin administration on lipid metabolism and platelet aggregation in hypertensive patients.
    Loschiavo C, Valvo E, Bedogna V, Casagrande P, Graziani MS, Nicoli M, Maschio G.
    Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):455-7. PubMed ID: 2272704
    [Abstract] [Full Text] [Related]

  • 4. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
    Amstein R, Fetkovska N, Pletscher A, Bühler FR.
    J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost.
    Palatianos GM, Foroulis CN, Vassili MI, Matsouka P, Astras GM, Kantidakis GH, Iliopoulou E, Melissari EN.
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):548-54. PubMed ID: 14762367
    [Abstract] [Full Text] [Related]

  • 8. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N, Kurt M, Wenk A, Winter J, Gams E, Hohlfeld T.
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [Abstract] [Full Text] [Related]

  • 9. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
    Bühler FR, Amstein R.
    Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The use of ketanserin, a 5-hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery.
    van der Starre PJ, Scheijgrond HW, Reneman RS, Kolling JB.
    Anesth Analg; 1983 Jan; 62(1):63-9. PubMed ID: 6600382
    [Abstract] [Full Text] [Related]

  • 13. Age-related effects of 5-HT2 antagonists.
    Doyle AE.
    J Cardiovasc Pharmacol; 1991 Jan; 17 Suppl 5():S29-34. PubMed ID: 1717770
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C, Maier S, Innerhofer P, Kolbitsch C, Streif W, Mittermayr M, Praxmarer M, Fries D.
    Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
    [Abstract] [Full Text] [Related]

  • 17. Acute and chronic changes in platelet volume and count after cardiopulmonary bypass induced thrombocytopenia in man.
    Martin JF, Daniel TD, Trowbridge EA.
    Thromb Haemost; 1987 Feb 03; 57(1):55-8. PubMed ID: 3590081
    [Abstract] [Full Text] [Related]

  • 18. Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists.
    Gleerup G, Persson B, Hedner T, Winther K.
    Eur J Clin Pharmacol; 1993 Feb 03; 44(2):121-5. PubMed ID: 8453957
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass.
    Tabata S, Yamaguchi S, Nagamine H, Tomita S, Arai S, Takemura H, Watanabe G.
    Eur J Cardiothorac Surg; 2004 Aug 03; 26(2):289-93. PubMed ID: 15296885
    [Abstract] [Full Text] [Related]

  • 20. Platelet serotonin-LDL interaction in essential hypertension.
    Amstein R, Fetkovska N, Bühler FR.
    J Cardiovasc Pharmacol; 1991 Aug 03; 17 Suppl 5():S35-40. PubMed ID: 1717771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.